Tourette??s Syndrome and Role??of??Tetrabenazine

Springer Science and Business Media LLC - Tập 28 Số 7 - Trang 443-459 - 2008
Mauro Porta1, Marco Sassi1, Mario Cavallazzi1, Maurizio Fornari1, Arianna Brambilla1, Domenico Servello1
1IRCCS Galeazzi Hospital

Tóm tắt

Từ khóa


Tài liệu tham khảo

Chowdhury, 2004, BMJ, 329, 1356, 10.1136/bmj.329.7479.1356

Muller, 2007, Dialogues Clin Neurosci, 9, 161, 10.31887/DCNS.2007.9.2/nmueller

Bruun, 1984, J Am Acad Child Psych, 23, 126, 10.1097/00004583-198403000-00002

Apter, 1993, Arch Gen Psych, 50, 734, 10.1001/archpsyc.1993.01820210068008

Singer, 2005, Lancet Neurology, 4, 149, 10.1016/S1474-4422(05)01012-4

Kurlan, 2001, Neurology, 57, 1383, 10.1212/WNL.57.8.1383

Coffey, 1997, Neurol Clin, 15, 277, 10.1016/S0733-8619(05)70312-1

Swain, 2007, J Am Acad Child Adolesc Psych, 46, 947, 10.1097/chi.0b013e318068fbcc

Robertson, 2006, Eur Child Adolesc Psychiatry, 15, 1, 10.1007/s00787-006-0505-z

Como, 2005, Advances Neurol, 96, 249

Goodman, 2006, J Child Neurol, 21, 704, 10.1177/08830738060210081201

Robertson, 2002, Eur Child Adolesc Psychiatry, 11, 261, 10.1007/s00787-002-0301-3

Robertson, 2006, J Affect Dis, 91, 265, 10.1016/j.jad.2005.12.046

Robertson, 2000, Brain, 123, 425, 10.1093/brain/123.3.425

Zinner, 2004, Contemporary Paediatrics, 21, 38

Coffey, 1992, Adv Neurol, 58, 95

Keen-Kim, 2006, J Child Neurol, 21, 665, 10.1177/08830738060210081101

Pauls, 2001, Adv Neurol, 85, 281

Leckman, 1990, J Am Acad Child Adolescent Psych, 29, 220, 10.1097/00004583-199003000-00010

Leckman, 1987, Arch Gen Psych, 44, 100, 10.1001/archpsyc.1987.01800130112025

Church, 2003, J Neurol Neurosurg Psych, 74, 602, 10.1136/jnnp.74.5.602

Mell, 2005, Pediatrics, 116, 56, 10.1542/peds.2004-2058

Hoekstra, 2004, Cellular Molecular Life Sci, 61, 886, 10.1007/s00018-003-3320-4

Berardelli, 2003, J Neurol, 250, 781, 10.1007/s00415-003-1102-4

Frey, 2006, J Child Neurol, 21, 672, 10.1177/08830738060210080501

Peterson, 1998, Arch Gen Psych, 55, 326, 10.1001/archpsyc.55.4.326

Serrien, 2005, Brain, 128, 116, 10.1093/brain/awh318

Francois, 2004, Brain, 127, 2055, 10.1093/brain/awh239

Grabli, 2004, Brain, 127, 2039, 10.1093/brain/awh220

Jankovic, 1992, Adv Neurol, 58, 7

Gaze, 2006, J Child Neurol, 21, 657, 10.1177/08830738060210081301

Robertson, 1989, Psychol Med, 19, 611, 10.1017/S0033291700024211

Mathews, 2004, J Neurol Neurosurg Psychiatry, 75, 1149, 10.1136/jnnp.2003.020693

Chatterjee, 2003, Mov Disord, 18, 703, 10.1002/mds.10427

Jain, 2006, Mov Disord, 21, 1966, 10.1002/mds.21063

Ondo, 1999, Am J Psychiatry, 156, 1279, 10.1176/ajp.156.8.1279

2006, Neurology, 66, 366, 10.1212/01.wnl.0000198586.85250.13

Kenney, 2007, Mov Disord, 22, 10, 10.1002/mds.21161

Sitburana, 2006, Mov Disord, 21, 2023, 10.1002/mds.21100

Vieregge, 1987, JNeurol, 235, 126

Jankovic, 1997, Neurology, 48, 358, 10.1212/WNL.48.2.358

Quinn, 1959, J Pharmacol Exp Ther, 127, 103

Butler, 1989, Eur J Pharmacol, 160, 93, 10.1016/0014-2999(89)90657-2

Tomlinson, 1977, Br J Pharmacol, 61, 339, 10.1111/j.1476-5381.1977.tb08425.x

Login, 1983, Proc Soc Exp Biol Med, 172, 225, 10.3181/00379727-172-41550

Login, 1982, Ann Neurol, 12, 257, 10.1002/ana.410120308

Reches, 1983, JPharmacol Exp Ther, 225, 515

Mehvar, 1987, J Pharm Sci, 76, 461, 10.1002/jps.2600760610

Zheng, 2006, AAPS J, 8, E682, 10.1208/aapsj080478

Pettibone, 1984, Eur J Pharmacol, 102, 425, 10.1016/0014-2999(84)90562-4

Mehvar, 1987, Drug Metab Dispos, 15, 250

Roberts, 1986, Eur J Clin Pharmacol, 29, 703, 10.1007/BF00615962

Silay, 2005, Expert Opinion Emerging Drugs, 10, 365, 10.1517/14728214.10.2.365

Scahill, 2006, NeuroRx, 3, 192, 10.1016/j.nurx.2006.01.009

Kenney, 2007, J Ped Neurol, 5, 9

Bartels, 1984, Eur Arch Psychiatry Neurol Sci, 234, 172, 10.1007/BF00461557

Hrachovy, 1988, Epilepsia, 29, 561, 10.1111/j.1528-1157.1988.tb03761.x

Jankovic, 1982, Ann Neurol, 11, 41, 10.1002/ana.410110108

Jankovic, 1984, Neurology, 34, 688, 10.1212/WNL.34.5.688

Jankovic, 1988, Neurology, 38, 391, 10.1212/WNL.38.3.391

Kenney, 2006, Expert Rev Neurother, 6, 7, 10.1586/14737175.6.1.7

Paleacu, 2004, Clin Neuropharmacol, 27, 230, 10.1097/01.wnf.0000136892.24629.96

Sandyk, 1987, Int J Neurosci, 37, 59, 10.3109/00207458708991801

Kenney, 2007, Mov Disord, 22, 193, 10.1002/mds.21222

Mikkelsen, 1983, Acta Neurol Scand, 68, 57, 10.1111/j.1600-0404.1983.tb04816.x

Burke, 1985, Ann Neurol, 17, 200, 10.1002/ana.410170217

Ossemann, 1996, Mov Disord, 11, 95, 10.1002/mds.870110118

Petzinger, 1997, Mov Disord, 12, 246, 10.1002/mds.870120219

Stevens, 1998, Intensive Care Med, 24, 369, 10.1007/s001340050583

Kenney, 2006, Clin Neuropharmacol, 29, 259, 10.1097/01.WNF.0000228369.25593.35

Fann, 1976, Am J Psychiatry, 133, 940, 10.1176/ajp.133.8.940

Kelly, 1971, J Clin Pharmacol New Drugs, 11, 211, 10.1177/009127007101100308

Gilbert, 2006, J Child Neurol, 21, 690, 10.1177/08830738060210080401

Kastrup, 2005, J Clin Psychopharmacol, 25, 94, 10.1097/01.jcp.0000150229.69124.66

Kim, 2005, J Child Adolescent Psychopharmacol, 15, 318, 10.1089/cap.2005.15.318

Murphy, 2005, Intern J Neuropsychopharmacol, 8, 489, 10.1017/S1461145705005365

Scahill, 2003, Neurology, 60, 1130, 10.1212/01.WNL.0000055434.39968.67